Caution: The following texts are translated from the Japanese original. We cannot take responsibility for ambiguity in the translation.

Designated Category 2 OTC medicine

リングルアイビーα200 RINGL IBα200

Product features

● Gel capsules formulated with ibuprofen, effective against pain, such as headache and menstrual pain.
● The active ingredient ibuprofen dissolves into liquid form.

Indication

(1) Relief of headache, toothache, pain after tooth extraction, sore throat (throat pain), earache, joint pain, neuralgia, lumbago, muscular pain, pain due to stiff shoulders, contusion pain, bone fracture pain, pain associated with sprain (sprain pain), painful menses (menstrual pain), and traumatic pain
(2) Relief of fever at the time of chills (feeling cold due to fever) and fever

Dosage and administration

When symptoms appear, take the following single dose. Avoid taking on an empty stomach as much as possible. Always leave at least 4 hours between doses.

<Age: single dose: number of daily doses>
Adults (over 15): 1 capsule: 2x as the limit
Under 15 years old: Do not take

Precautions of Dosage and Administration

(1)Strictly follow the prescribed dosage and administration.
(2) How to Dispense Capsules
 Using a finger, push the convex portion of the PTP sheet containing capsules to break the aluminum foil on the back.
(Can lead to unforeseen consequences such as piercing the esophageal mucosa if mistakenly swallowed)"

Ingredient and amount

In 1 capsules
Ibuprofen :200mg:Alleviates headache, menstrual pain, toothache and other. Reduces fever.

Precautions

■When not to use the product
(If you do not follow these instructions, the current symptoms may worsen or adverse reactions/incidents are more likely to occur.)
1.This product should not be taken by the following persons.
(1)Those who have experienced allergic symptoms to this medication or any of its ingredients
(2)Patients who have experienced asthma from taking this drug, other antipyretic analgesics, cold remedies.
 (May induce asthma)
(3)Children under 15 years old.
(4)Those taking medicine or undergoing treatment at a medical institution for the following diseases.
 Gastric/duodenal ulcer, blood disease, liver disease, kidney disease, heart disease, high blood pressure, or those taking zidovudine (Retrovir).
 (May worsen symptoms in people with gastric/duodenal ulcers, liver disease, and kidney disease)
 May cause leukopenia or thrombocytopenia in those with blood diseases, and may additionally worsen symptoms)
 (May additionally worsen symptoms of cardiac dysfunction in those with heart disease)
 (May additionally increase blood pressure in those with hypertension)
(5) Pregnant women who are expected to given birth within 12 weeks.
2.This drug should not be taken together with the following drugs:
Other antipyretics/analgesics, cold medicine, sedatives
3.Do not drink alcohol before/after taking this medicine
 (Generally, alcohol accelerates absorption of medication and speeds up metabolism, and since this increases the occurrence of side effects and toxicity, it may result in severe liver damage.)
4.Do not take this medicine for a long time

■Consultation
1.The following persons should contact a physician, dentist, pharmacist, or registered salesperson for a consultation before administration.
(1)Patients undergoing medical treatment from a physician or dentist.
(2)Pregnant women or women suspected of being pregnant.
(3)Nursing women.
(4)The elderly
 (In general, since elderly people have declined physical functions, this may cause stronger side effects.)
(5)Patients who have experienced allergic symptoms associated with drugs, etc.
(6) Persons diagnosed as having the following or patients who experienced any of the following diseases.
Gastric/duodenal ulcer, blood disease, liver disease, kidney disease, heart disease, hypertension, bronchial asthma (may induce bronchial asthma), systemic lupus erythematosus (symptoms associated with this disease such as kidney damage may worsen, and aseptic meningitis may occur) mixed connective tissue disease (aseptic meningitis may occur)), ulcerative colitis, Crohn's disease (worsening of symptoms has been reported)
2.If the following symptoms are observed after taking this drug, these may be adverse reactions, so immediately discontinue the use of this drug, and show this document to your physician, dentist, pharmacist, or registered salesperson for a consultation.


Skin:rash/redness,itching, bruised
Gastrointestinal system: nausea and vomiting, loss of appetite, feeling of discomfort in the stomach, stomachache, stomatitis, heartburn, stomach heaviness, gastrointestinal bleeding,abdominal pain, diarrhea, bloody stool,
Neuropsychiatric system:dizziness, drowsiness, insomnia, feel depressed
Cardiovascular system:palpitations
Respiratory system: shortness of breath
Other:blurred vision,ear ringing, edema, nose bleeds, bleeding of the gums, difficult to stop bleeding, bleeding, , back pain, excessive temperature decrease, general malaise

The following serious symptoms may occur in rare cases. In such cases, immediately seek medical aid:
<Symptom name: Symptoms>
Shock (anaphylaxis): Symptoms, such as itching of skin, urticaria, hoarseness, sneezing, itchy throat, breathing difficulties, palpitations, and clouding of consciousness may occur immediately after take.
Oculomucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis: Hyperthermia, ocular hyperaemia, eye discharge, lip erosion, pain throat, widespread skin rash/redness, etc. may persist or suddenly worsen.
Hepatic function failure: Symptoms, such as fever, itching, rash, jaundice (yellowing of skin and white of eyes), brown urine, general malaise, loss of appetite, etc. may occur.
Kidney disorders: Symptoms, such as fever, rash, reduced urinary volume, general oedema, general malaise, arthralgia (painful joints) and diarrhea, etc. may occur.
Aseptic meningitis: Symptoms, such as severe headache with a tight sensation along the neck, fever and feeling nausea/vomiting, etc. may occur. (these symptoms are frequently reported particularly in patients under treatment for systemic lupus erythematosus or mixed connective tissue disease. )
Asthma: Symptoms, such as wheezing or hissing when breathing, and difficult breathing, etc. may occur.
Aplastic anemia: Symptoms, such as bruises, nose bleeds, bleeding gums, fever, pale appearance of skin and mucosa, fatigue, palpitations, shortness of breath, becoming dizzy from feeling sick and blood in the urine, etc. may occur.
Agranulocytosis: Symptoms, such as acute high fever, chills and sore throat, etc. may occur.

3.The following symptoms may be observed after taking this drug. If these symptoms persist or worsen , discontinue the use of this drug, and show this document to your physician, pharmacist, or registered salesperson for a consultation.
Constipation, dry mouth
4.The following symptoms may be observed after taking this drug: your body temperature drops below normal, you feel lethargic (lethargy), or your hands and feet get cold (natura frigida in the extremities). In such cases, immediately discontinue the use of this drug, keep you warm with a blanket and show this document to your physician, pharmacist, or registered salesperson for a consultation.
5.When symptoms do not improve even after taking the medicine 3 to 4 times, stop taking this medicine and consult a physician, dentist, pharmacist or registered salesperson, being sure to take this instruction leaflet with you.

Additive

Polysorbate 80, hydroxylated K, gelatin, succinated gelatin, sugar alcohol derived from corn starch, gardenia pigment

Precautions for storage and handling

(1)Store in a cool, low humidity place away from direct sunlight.
(2)Keep out of reach of children.
(3)Do not transfer the medicine to a different container. (It may lead to misuse or alter the quality of the drug. )
(4)Do not take the product after its expiration date.
(5)Capsules absorb moisture. Do not touch with wet hands.

Disclaimer on Multilingual Product Information

・This product is a pharmaceutical product approved under a Japanese law, the Law for Ensuring the Quality, Efficacy and Safety of Drugs and Medical Devices, with a view to its sale and use in Japan.

・Multilingual product information is a translation of the product labeling written in Japanese and provided for your information only. It does not warrant that its contents and the product itself conforms to laws and regulations in countries other than Japan.

・Multilingual product information is a tentative translation by Our Company, and may be modified or altered without notice.

・Our Company assumes no responsibility for any occurred problem attributable to the contents of the multilingual product information.